Healthcare Global December 23, 2021
Helen Adams

Stephen Hoelper, Doceree President, North America, has some expectations for 2022 – here’s five ways he thinks tech will impact the Life Sciences Industry

Stephen Hoelper is President, North America of Doceree, the first global network of HCP-only platforms for programmatic messaging. Doceree is aiming to address the acute problem of rising cost of healthcare by bringing in efficiency and effectiveness in messaging to healthcare professionals by life sciences brands on digital platforms with methodical use of data and creativity.

Stephen has experience throughout his career conceptualising and realising healthcare go-to market strategies for start-ups and Fortune 50 companies.

Here, he shares with Healthcare, his predictions for 2022.

The landscape of the life sciences industry has transformed during the pandemic...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Digital Health, FDA, Govt Agencies, Metaverse/VR, Pharma / Biotech, Technology, Telehealth, Voice Assistant, Wearables
STAT+: After AI protein folding, David Baker’s lab identifies millions of smaller drug candidates
Fierce Biotech Layoff Tracker 2024: BMS to cut 2K+ roles; Tessera trims workforce in shift to clinic
What Do Weight-Loss Drugs Mean for Diet Industry Built on Eating Less and Exercise?
Podcast #1: Doing Digital Deals in Life Sciences | Corporate Culture
BMS plans $1.5B in cuts through '25, with 2000-plus layoffs

Share This Article